James C Chen

Shares of Eagle Pharmaceuticals Inc (NASDAQ: EGRX) continue to rise on Monday, as they have been doing since the beginning of the year. Earlier this morning, RBC Capital Markets analysts Randall Stanicky and James C Chen initiated coverage on the stock with an Outperform rating and a $97.00 price...